In conclusion, our study divided ccRCC into distinct immune clusters and thereby identified two DEGs, namely, PTPRG and CHL1, which were validated to play a crucial role in inhibiting tumor growth and might be responsible for the formation of distinct immune clusters in ccRCC. Here, CHL1 is linked to neoplasm.